Skip to main content

Table 1 Characteristics of meningioma samples included in the discovery set

From: Transcriptome signatures associated with meningioma progression

Patient

BTTB ID

Gender

WHO Grade

Brain Invasion

Tumor location

Follow Up Years

1a

3043

M

I P

N

Left cerebellopontine angle

3

 

3261

 

II S

N

Foramen magnum

 

2

2536

M

I P

N

Right temporal lobe

7.5

 

4995

 

II S

Y

Right temporal lobe

 

3

1981

F

I P

N

Left parasagittal falcine convexity

9

 

4302

 

II S

N

Left frontal lobe

 

4a

1818

 

II DN

N

Right frontal lobe

9.4

 

3254

F

III S

N

Posterior right frontal lobe

 
 

3526

 

III S

N

Right parietal lobe

 

5a

3909

F

I NP

N

Right parietal lobe

5.4

6

2960_2

F

I NP

N

Right frontal lobe

7.6

7

3402_2

F

I NP

N

Left frontal parafalcine

1.6

8

3478

F

I NP

N

Left occipital lobe

6.6

9

3861

F

I NP

N

Left occipital lobe

5.5

10

2909_2

F

I NP

N

Right frontal lobe

7.8

11

2788b

F

II S

N

Right cerebellopontine angle

2.9

12

4084

F

II DN

Y

Parasagittal

3.8

13

4142

M

II DN

Y

Right parietal lobe

5.2

14

2993

F

II DN

Y

Left frontal lobe

8.3

15

2771

F

II DN

N

Right parietal lobe

3.6

16

2290

F

II DN

Y

Planum sphenoidale

2.5

17

4836

F

II DN

Y

Parasagittal

3.9

18

2516

M

III DN

N

Right frontal parasagittal

3

19

2860

F

III DN

Y

Left frontal lobe

7.3

20

5231

M

III DN

N

Right frontal lobe

2.8

  1. I P Grade I that Progressed, S Secondary, DN De Novo, I NP Grade I that Never Progressed
  2. apatient has prior history of radiation
  3. bgrade II that progressed from a grade I tumor